Disposition of 13988 shares by August Troendle of Medpace Holdings at 386. subject to Rule 16b-3

MEDP Stock  USD 337.28  2.13  0.64%   
Slightly above 57% of all Medpace Holdings' retail investors are looking to take a long position. The analysis of overall sentiment of trading Medpace Holdings stock suggests that some investors are interested at this time. Medpace Holdings' investing sentiment overview a quick insight into current market opportunities from investing in Medpace Holdings. Many technical investors use Medpace Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Medpace Holdings Director, 10 Percent Owner, Officer: Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 13988 common stock at 386.39 of Medpace Holdings by August Troendle on 20th of February 2024. This event was filed by Medpace Holdings with SEC on 2024-02-20. Statement of changes in beneficial ownership - SEC Form 4. August Troendle currently serves as chairman of the board and presidentident, ceo of Medpace Holdings

Cash Flow Correlation

Medpace Holdings' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Medpace Holdings' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Medpace Holdings Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Medpace Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Medpace Holdings Fundamental Analysis

We analyze Medpace Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medpace Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medpace Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Medpace Holdings is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Medpace Holdings Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medpace Holdings stock to make a market-neutral strategy. Peer analysis of Medpace Holdings could also be used in its relative valuation, which is a method of valuing Medpace Holdings by comparing valuation metrics with similar companies.

Peers

Medpace Holdings Related Equities

STTKShattuck Labs   6.48   
0%
59.0%
IPSCCentury Therapeutics   4.76   
0%
44.0%
RZLTRezolute   3.78   
0%
34.0%
ADAGAdagene   1.99   
0%
18.0%
MNOVMediciNova   0.46   
0%
4.0%
ACRVAcrivon Therapeutics,   0.30   
0%
2.0%
AVTEAerovate Therapeutics   1.17   
10.0%
0%
MOLNMolecular Partners   2.68   
24.0%
0%
ANEBAnebulo Pharmaceuticals   10.81   
100.0%
0%

Additional Tools for Medpace Stock Analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.